Please use this identifier to cite or link to this item: https://saber.ucv.ve/jspui/handle/10872/12533
Full metadata record
DC FieldValueLanguage
dc.contributor.authorConvit, J.-
dc.contributor.authorUlrich, M.-
dc.contributor.authorFemández, C. T.-
dc.contributor.authorTapia, Félix J.-
dc.contributor.authorCáceres-Dittmar, G.-
dc.contributor.authorCastés, M.-
dc.contributor.authorRondón, A.J.-
dc.date.accessioned2015-10-30T19:42:41Z-
dc.date.available2015-10-30T19:42:41Z-
dc.date.issued1993-
dc.identifier.urihttp://hdl.handle.net/10872/12533-
dc.description.abstractAmerican cutaneous leishmaniasis is characterized by a spectrum of elinical manifestations. These inelude localized, often self-healing single lesions, interrnediate forms which frequently produce mucosallesions and often show exaggerated delayed-type hypersensitivity (DTH), and the rare diffuse cutaneous leishmaniasis in -:vhichn~ reaction o~ protect!ve cell-rnediated irnmunity or DTH can be dernonstrated. Clinical, pathological and immunological studies have begun to unravel some of the mechanisms associated with different disease manifestations, dependent on complex interactions between the host irnmune response, measured in terms of indices including lyrnphocyte subsets and lymphokines in vitro and within active lesions, and different species of Leishmania.es_VE
dc.language.isoenes_VE
dc.publisherTRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE ANO HYGIENEes_VE
dc.relation.ispartofseries;87-
dc.subjectimmunological spectrumes_VE
dc.subjectleishmaniasises_VE
dc.titleThe clinical and immunological spectrum of American cutaneous leishmaniasises_VE
dc.typeArticlees_VE
Appears in Collections:Artículos Publicados

Files in This Item:
File Description SizeFormat 
The clinical and immunological spectrum of American cutaneous leishmaniasis.pdf5.82 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.